Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASAH1 | Q13510 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.68 |
| ▸ | CERT1 | Q9Y5P4 | 3/20 | 0.66 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.54 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7769010 | 1.00 | ASAH1 (0.68) | ASAH1ALDH1A1ACER2CERT1GPR88 | |
| SCHEMBL7769012 | 1.00 | ASAH1 (0.68) | ASAH1ALDH1A1ACER2CERT1GPR88 | |
| SCHEMBL6570067 | 1.00 | ASAH1 (0.68) | ASAH1ALDH1A1ACER2CERT1GPR88 | |
| SCHEMBL28217435 | 0.90 | ASAH1 (0.66) | ASAH1ALDH1A1ACER2CERT1 | |
| SCHEMBL9848504 | 0.87 | ASAH1 (0.63) | ASAH1ALDH1A1ACER2CERT1 | |
| SCHEMBL9716121 | 0.87 | ASAH1 (0.63) | ASAH1ALDH1A1ACER2CERT1 | |
| SCHEMBL27758299 | 0.85 | ASAH1 (0.60) | ASAH1ALDH1A1ACER2CERT1 | |
| SCHEMBL9716137 | 0.85 | ASAH1 (0.61) | ASAH1ALDH1A1ACER2CERT1 | |
| SCHEMBL9716138 | 0.85 | ASAH1 (0.61) | ASAH1ALDH1A1ACER2CERT1 | |
| SCHEMBL7413120 | 0.85 | ASAH1 (0.60) | ASAH1ALDH1A1ACER2CERT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5990170-A | POSSESSES A PROFILE OF ACTIVITY WHICH IS SIMILAR TO, THOUGH LESS POTENT THAN .DELTA.9-THC (TETRAHYDROCANNABINOL) WITH A MIMICKING OF THE PSYCHOACTIVE EFFECTS; ANALGESICS; SIDE EFFECT REDUCTION; CARDIOVASCULAR DISORDERS | LIFEGROUP S.P.A. (IT) | 1999-11-23 | — | — | US | disclosed |
| EP-0799033-A1 | USE OF MONO AND BICARBOXYLIC ACID AMIDES FOR THE MANUFACTURE OF A MEDICAMENT ACTIVE AT THE PERIPHERAL CANNABINOID RECEPTOR | LIFEGROUP S.p.A. (IT) | 1997-10-08 | — | — | EP | disclosed |
| WO-1996018391-A2 | USE OF MONO AND BICARBOXYLIC ACID AMIDES FOR THE MANUFACTURE OF A MEDICAMENT ACTIVE AT THE PERIPHERAL CANNABINOID RECEPTOR | LIFEGROUP S.P.A. (IT) | 1996-06-20 | — | — | WO | disclosed |